• Please log in or register to access this feature.

RESEARCH ARTICLE

You have free access to this content

The Behavioral Phenotype in MECP2 Duplication Syndrome: A Comparison With Idiopathic Autism

  1. Sarika U. Peters1,2,*,
  2. Rachel J. Hundley1,2,
  3. Amy K. Wilson2,
  4. Zachary Warren1,2,
  5. Alison Vehorn2,
  6. Claudia M.B. Carvalho3,
  7. James R. Lupski3,
  8. Melissa B. Ramocki4

Article first published online: 20 NOV 2012

DOI: 10.1002/aur.1262

Issue

Autism Research

Autism Research

Volume 6, Issue 1, pages 42–50, February 2013

Additional Information

How to Cite

Peters, S. U., Hundley, R. J., Wilson, A. K., Warren, Z., Vehorn, A., Carvalho, C. M.B., Lupski, J. R. and Ramocki, M. B. (2013), The Behavioral Phenotype in MECP2 Duplication Syndrome: A Comparison With Idiopathic Autism. Autism Res, 6: 42–50. doi: 10.1002/aur.1262

Author Information

  1. 1

    Departments of Pediatrics and Psychiatry, Vanderbilt University, Nashville, Tennessee

  2. 2

    Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee

  3. 3

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas

  4. 4

    Department of Pediatrics, Section of Pediatric Neurology and Developmental Neuroscience, Baylor College of Medicine, Houston, Texas

*Address for correspondence and reprints: Sarika U. Peters, Vanderbilt Kennedy Center, PMB 74; 230 Appleton Place, Nashville, TN 37203-5721. Email: sarika.u.peters@vanderbilt.edu

  1. From the Departments of Pediatrics and Psychiatry, Vanderbilt University, Nashville, Tennessee (S.U.P., R.J.H., Z.W.); Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee (S.U.P., R.J.H., A.K.W., Z.W., A.V.); Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas (C.C., J.R.L.); Department of Pediatrics, Section of Pediatric Neurology and Developmental Neuroscience, Baylor College of Medicine, Houston, Texas (M.B.R.)

Publication History

  1. Issue published online: 20 FEB 2013
  2. Article first published online: 20 NOV 2012
  3. Manuscript Accepted: 16 OCT 2012
  4. Manuscript Received: 26 APR 2012

Funded by

  • Vanderbilt Kennedy Center Hobbs Discovery Grant. Grant Number: 5P30HD015052-30
  • NINDS grant. Grant Number: 5K08NS062711

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (351K)

References

  • Ariani, F., Mari, F., Pescucci, C., Longo, I., Bruttini, M., et al. (2004). Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication. Human Mutation, 24, 172–177.
    Direct Link:
  • Bishop, S.L., Guthrie, W., Coffing, M., & Lord, C. (2011). Convergent validity of the Mullen Scales of Early Learning and the differential ability scales in children with autism spectrum disorders. American Association on Intellectual and Developmental Disabilities, 116, 331–343.
  • Carney, R.M., Wolpert, C.M., Ravan, S.A., Shahbazian, M., Ashley-Koch, A., et al. (2003). Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatric Neurology, 28, 205–211.
  • Carvalho, C.M., Ramocki, M.B., Pehlivan, D., Franco, L.M., Gonzaga-Jauregui, C., et al. (2011). Inverted genomic segments and complex triplication rearrangements are mediated by inverted repeats in the human genome. Nature Genetics, 43, 1074–1081.
  • Carvalho, C.M., Zhang, F., Liu, P., Patel, A., Sahoo, T., et al. (2009). Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching. Human Molecular Genetics, 18, 2188–2203.
  • Cobb, S., Guy, J., & Bird, A. (2010). Reversibility of functional deficits in experimental models of Rett syndrome. Biochemical Society Transactions, 38, 498–506.
  • Coury, D., Jones, N.E., Klatka, K., Winklosky, B., & Perrin, J.M. (2009). Healthcare for children with autism: The Autism Treatment Network. Current Opinion in Pediatrics, 21, 828–832.
  • Coutinho, A.M., Oliveira, G., Katz, C., Feng, J., Yan, J., et al. (2007). MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B, 475–483.
    Direct Link:
  • del Gaudio, D., Fang, P., Scaglia, F., Ward, P.A., Craigen, W.J., et al. (2006). Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genetics in Medicine, 8, 784–792.
  • Dolen, G., Carpenter, R.L., Ocain, T.D., & Bear, M.F. (2010). Mechanism-based approaches to treating Fragile X. Pharmacology and Therapeutics, 127, 78–93.
  • Downs, J., Geranton, S.M., Bebbington, A., Jacoby, P., Bahi-Buisson, N., et al. (2010). Linking MECP2 and pain sensitivity: The example of Rett syndrome. American Journal of Medical Genetics. Part A, 152A, 1197–1205.
    Direct Link:
  • Foss-Feig, J.H., Heacock, J.L., & Cascio, C.J. (2012). Tactile responsiveness patterns and their association with core features in autism spectrum disorders. Research in Autism Spectrum Disorders, 6, 337–344.
  • Friez, M.J., Jones, J.R., Clarkson, K., Lubs, H., Abuelo, D., et al. (2006). Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics, 118, e1687–e1695.
  • Geranton, S.M., Fratto, V., Tochiki, K.K., & Hunt, S.P. (2008). Descending serotonergic controls regulate inflammation-induced mechanical sensitivity and methyl-CpG-binding protein 2 phosphorylation in the rat superficial dorsal horn. Molecular Pain, 4, 35.
  • Geschwind, D.H. (2011). Genetics of autism spectrum disorders. Trends in Cognitive Sciences, 15, 409–416.
  • Gotham, K., Risi, S., Dawson, G., Tager-Flusberg, H., Joseph, R., et al. (2008). A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 642–651.
  • Gotham, K., Risi, S., Pickles, A., & Lord, C. (2007). The Autism Diagnostic Observation Schedule: Revised algorithms for improved diagnostic validity. Journal of Autism and Developmental Disorders, 37, 613–627.
  • Grasshoff, U., Bonin, M., Goehring, I., Ekici, A., Dufke, A., et al. (2011). De novo MECP2 duplication in two females with random X-inactivation and moderate mental retardation. European Journal of Human Genetics, 19, 507–512.
  • Kuwano, Y., Kamio, Y., Kawai, T., Katsuura, S., Inada, N., et al. (2011). Autism-associated gene expression in peripheral leucocytes commonly observed between subjects with autism and healthy women having autistic children. PLoS One, 6, e24723.
  • Liu, J., & Francke, U. (2006). Identification of cis-regulatory elements for MECP2 expression. Human Molecular Genetics, 15, 1769–1782.
  • Loat, C.S., Curran, S., Lewis, C.M., Duvall, J., Geschwind, D., et al. (2008). Methyl-CpG-binding protein 2 polymorphisms and vulnerability to autism. Genes, Brain, and Behavior, 7, 754–760.
    Direct Link:
  • Lord, C., & Bishop, S.L. (2009). The autism spectrum: Definitions, assessment and diagnoses. British Journal of Hospital Medicine, 70, 132–135.
  • Lord, C., Petkova, E., Hus, V., Gan, W., Lu, F., et al. (2012). A multisite study of the clinical diagnosis of different autism spectrum disorders. Archives of General Psychiatry, 69, 306–313.
  • Lugtenberg, D., Kleefstra, T., Oudakker, A.R., Nillesen, W.M., Yntema, H.G., et al. (2009). Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy. European Journal of Human Genetics, 17, 444–453.
  • Meins, M., Lehmann, J., Gerresheim, F., Herchenbach, J., Hagedorn, M., et al. (2005). Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. Journal of Medical Genetics, 42, e12.
  • Piton, A., Gauthier, J., Hamdan, F.F., Lafreniere, R.G., Yang, Y., et al. (2011). Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Molecular Psychiatry, 16, 867–880.
  • Ramocki, M.B., Peters, S.U., Tavyev, Y.J., Zhang, F., Carvalho, C.M., et al. (2009). Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Annals of Neurology, 66, 771–782.
    Direct Link:
  • Ramocki, M.B., Tavyev, Y.J., & Peters, S.U. (2010). The MECP2 duplication syndrome. American Journal of Medical Genetics. Part A, 152A, 1079–1088.
    Direct Link:
  • Ramocki, M.B., & Zoghbi, H.Y. (2008). Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature, 455, 912–918.
  • Samaco, R.C., Fryer, J.D., Ren, J., Fyffe, S., Chao, H.T., et al. (2008). A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Human Molecular Genetics, 17, 1718–1727.
  • Samaco, R.C., Mandel-Brehm, C., Chao, H.T., Ward, C.S., Fyffe-Maricich, S.L., et al. (2009). Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proceedings of the National Academy of Sciences of the United States of America, 106, 21966–21971.
  • Samaco, R.C., Mandel-Brehm, C., McGraw, C.M., Shaw, C.A., McGill, B.E., & Zoghbi, H.Y. (2012). Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nature Genetics, 44, 206–211.
  • Sanders, S.J., Ercan-Sencicek, A.G., Hus, V., Luo, R., Murtha, M.T., et al. (2011). Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron, 70, 863–885.
  • Shibayama, A., Cook, E.H., Jr, Feng, J., Glanzmann, C., Yan, J., et al. (2004). MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 128B, 50–53.
    Direct Link:
  • State, M.W., & Levitt, P. (2011). The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neuroscience, 14, 1499–1506.
  • Van Esch, H. (2012). MECP2 Duplication Syndrome. Molecular Syndromology, 2, 128–136.
  • Van Esch, H., Bauters, M., Ignatius, J., Jansen, M., Raynaud, M., et al. (2005). Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. American Journal of Human Genetics, 77, 442–453.
  • Veenstra-VanderWeele, J., & Blakely, R.D. (2012). Networking in autism: Leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology, 37, 196–212.
View Full Article (HTML) Get PDF (351K)